Lifengine Animal Health Laboratories Incorporated
- UEI
- N8JEWCR8XZL4
- CAGE
- 8AWY2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- leahlabs.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| C-MYB overexpression for exhaustion resistant car-t cell therapies - summary chimeric antigen receptor or car-t cells… | National Cancer Institute | $400,000 | |
| Sbir phase II: clinical scale and testing of the first virus-free precision gene edited cell therapy for veterinary… | National Science Foundation | $1,668,708 | |
| A non-viral gene editing platform for cell therapies and translational autoimmune disease modeling - summary gene edited… | National Center for Advancing Translational Sciences | $674,866 | |
| Sbir phase i: a non-viral gene editing platform for cell therapies in the veterinary market | Division of Industrial Innovation | $225,000 |
About Lifengine Animal Health Laboratories Incorporated
Lifengine Animal Health Laboratories Incorporated is a for-profit corporate entity registered in SAM.gov, headquartered in Eagan, Minnesota. The company appears to specialize in advanced cellular engineering technologies, with a particular focus on developing innovative gene editing platforms and cell therapies for veterinary and human medical applications. Their proprietary GeneWeld gene editing technology enables precise cellular modifications, positioning them as a cutting-edge biotechnology research organization with significant capabilities in developing chimeric antigen receptor (CAR)-T cell therapies.
The company has received federal grant awards from multiple prestigious agencies, including the National Cancer Institute, National Science Foundation, and National Center for Advancing Translational Sciences. Their grant-funded research has concentrated on developing advanced CAR-T cell therapies for both veterinary and human oncology applications, with specific projects addressing challenges like cell therapy manufacturing scale, reducing cellular exhaustion, and creating virus-free precision gene-edited therapies. For instance, they received a $400,000 grant from the National Cancer Institute to develop CAR-T cells that can overcome functional exhaustion by overexpressing the C-MYB transcription factor, and a cooperative agreement with the National Science Foundation to develop clinical-scale cell therapy platforms for veterinary oncology. Additionally, they have participated in sub-awards, such as a collaboration with Mayo Clinic involving xenogeneic human CAR-T cell research using innovative imaging techniques to track cell expansion and trafficking in canine lymphoma models.
Quick answers
What is Lifengine Animal Health Laboratories Incorporated's UEI?
Lifengine Animal Health Laboratories Incorporated's Unique Entity ID (UEI) in SAM.gov is N8JEWCR8XZL4.
What is Lifengine Animal Health Laboratories Incorporated's CAGE code?
Lifengine Animal Health Laboratories Incorporated's CAGE code is 8AWY2.
What is Lifengine Animal Health Laboratories Incorporated's primary NAICS code?
Lifengine Animal Health Laboratories Incorporated's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Lifengine Animal Health Laboratories Incorporated registered in SAM.gov?
Lifengine Animal Health Laboratories Incorporated's SAM.gov registration expired on September 3, 2026.
What is Lifengine Animal Health Laboratories Incorporated's most recent federal award?
Lifengine Animal Health Laboratories Incorporated's most recent federal grant award is C-MYB overexpression for exhaustion resistant car-t cell therapies - summary chimeric antigen receptor or car-t cells… (R43CA295178), from National Cancer Institute, on August 4, 2025.
On GovTribe
See Lifengine Animal Health Laboratories Incorporated's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors